SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹121 Cr | ₹122 Cr | ₹117 Cr | ₹85 Cr | ₹57 Cr |
What is the latest Total Liabilities ratio of SAMRAT PHARMACHEM ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹121 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹117 Cr |
| Mar2022 | ₹85 Cr |
| Mar2021 | ₹57 Cr |
How is Total Liabilities of SAMRAT PHARMACHEM Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹121 Cr | -0.20 | |
| Mar2024 | ₹122 Cr | 4.41 | |
| Mar2023 | ₹117 Cr | 37.79 | |
| Mar2022 | ₹85 Cr | 47.42 | |
| Mar2021 | ₹57 Cr | - | |
Compare Total Liabilities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹66.1 Cr | 1.6% | 9.4% | -44% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | 1.6% |
9.4% |
-44% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses